Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
60 participants
INTERVENTIONAL
2026-01-31
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exercise, Executive Processes and the Aging Brain
NCT00430976
Reducing Blood Pressure in Mid-life Adult Binge Drinkers
NCT05522075
Influence of Fitness on Brain and Cognition
NCT00438347
Resistance Training and Neuroimaging
NCT03982550
Exercise Effects on Brain Health and Learning From Minutes to Months
NCT03114150
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental condition 1
Participants allocated to the Experimental condition 1 will be following a aerobic exercise training program.
Aerobic Exercise
Participants allocated to the Aerobic condition will be following a 4 month-intervention aerobic exercise protocol of 3 weekly interleaved sessions with a 50 minutes duration
Experimental condition 2
Participants allocated to the Experimental condition 2 will be following an agility-cognitive exercise training program.
Agility-Cognitive Exercise
Participants allocated to the Agility-Cognitive condition will be following a 4 month-intervention agility-cognitive exercise protocol of 3 weekly interleaved sessions with a 50 minutes duration
Control condition
Participants allocated to the Control condition will be following a stretching/relaxation training program.
Stretching/relaxation
Participants allocated to the stretching control condition will be following a 4 month-intervention protocol of 1 weekly session with a 50 minutes duration
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Aerobic Exercise
Participants allocated to the Aerobic condition will be following a 4 month-intervention aerobic exercise protocol of 3 weekly interleaved sessions with a 50 minutes duration
Agility-Cognitive Exercise
Participants allocated to the Agility-Cognitive condition will be following a 4 month-intervention agility-cognitive exercise protocol of 3 weekly interleaved sessions with a 50 minutes duration
Stretching/relaxation
Participants allocated to the stretching control condition will be following a 4 month-intervention protocol of 1 weekly session with a 50 minutes duration
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* in the same time window (±2h)
* at least once per month
* \<150 minutes of physical activity per week
Exclusion Criteria
* Physical limitations that may constraint the practice of exercise
* Cardiovascular and respiratory insufficiency
* History of traumatic brain injury or neurological disorder
* Non-corrected sensory deficits
* Personal history of psychopathological disorders
* Family history of alcoholism or substance abuse in first degree relatives
* Consumption of medical drugs with psychoactive effects (e.g., sedatives or anxiolytics) during the month previous to the assessment
* Use of illegal drugs and AUDIT scores \>20
* MRI contraindications
* Current or previous (past year) participation in a physical exercise program
18 Years
24 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Minho
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sonia Sousa
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sónia Sousa, PhD
Role: PRINCIPAL_INVESTIGATOR
Research Center in Psychology, School of Psychology, University of Minho
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UMinho1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.